SSA
GNMK

Schonfeld Strategic Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,000
Closed -$1.2M – 2544
2021
Q1 		$1.2M Buy
+50,000
New +$929K 0.01% 824

Schonfeld Strategic Advisors's GNMK Position: Q2 2021 in Review

Schonfeld Strategic Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 20,000 shares — an estimated $478K sold.

Schonfeld Strategic Advisors first reported a position in GNMK in Q1 2017 and held it in 15 quarters. The position peaked at $4.87M in Q2 2017. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Schonfeld Strategic Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 20,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $478K.
  • Schonfeld Strategic Advisors first reported a position in GenMark Diagnostics, Inc in Q1 2017 and held it in 15 quarters.
  • Schonfeld Strategic Advisors's GenMark Diagnostics, Inc position peaked at $4.87M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.